Image‐Based Analysis to Predict the Activity of Tariquidar Analogs as P‐Glycoprotein Inhibitors: The Importance of External Validation

Permeability glycoprotein (P‐gp) is involved in the pathology of various diseases including cancer and epilepsy, mainly through the translocation of some medicines across the cell membrane. Here, we employed image‐based quantitative structure–activity relationship (QSAR) models to predict the P‐gp inhibitory activity of some Tariquidar derivatives. The structures of 65 Tariquidar derivatives and their P‐gp inhibition activities were collected from the literature. For each compound, the pixels of bidimensional images and their principal components (PCs) were calculated using MATLAB software. Various statistical methods including principal component regression, artificial neural networks, and support vector machines were employed to investigate the correlation between the PCs and the activity of the compounds. The predictability of the models was investigated using external validation and applicability domain analysis. An artificial neural network‐based model demonstrated the best prediction results for the test set. Moreover, external validation analysis of the developed models supports the idea that R2 cannot assure the validity of QSAR models and another criterion, i.e., the concordance correlation coefficient (CCC) parameter, should be involved to evaluate the validity of the QSAR models. The results of this study indicate that image analysis could be as suitable as descriptors calculated by commercial software to predict the activity of drug‐like molecules.

[1]  Matheus P Freitas,et al.  Predicting boiling points of aliphatic alcohols through multivariate image analysis applied to quantitative structure-property relationships. , 2008, The journal of physical chemistry. A.

[2]  Matheus P Freitas,et al.  Introducing new dimensions in MIA-QSAR: a case for chemokine receptor inhibitors. , 2013, European journal of medicinal chemistry.

[3]  Douglas M. Hawkins,et al.  The Problem of Overfitting , 2004, J. Chem. Inf. Model..

[4]  Desmond J. Maddalena Review Biologicals & Immunologicals: Applications of artificial neural networks to quantitative structure-activity relationships , 1996 .

[5]  H. Coley,et al.  Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein. , 2003, Cancer control : journal of the Moffitt Cancer Center.

[6]  Humayun Kabir,et al.  Comparative Studies on Some Metrics for External Validation of QSPR Models , 2012, J. Chem. Inf. Model..

[7]  P. Charlton,et al.  Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives. , 1999, Bioorganic & medicinal chemistry letters.

[8]  A. Tropsha,et al.  Beware of q2! , 2002, Journal of molecular graphics & modelling.

[9]  Abolghasem Jouyban,et al.  QSAR analysis of diaryl COX-2 inhibitors: comparison of feature selection and train-test data selection methods. , 2010, European journal of medicinal chemistry.

[10]  Frank R Burden,et al.  Quantitative structure-property relationship modeling of diverse materials properties. , 2012, Chemical reviews.

[11]  Richard Jensen,et al.  QSRR modeling for diverse drugs using different feature selection methods coupled with linear and nonlinear regressions. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[12]  Sarah Seifert,et al.  Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape , 2013, Nature Biotechnology.

[13]  A. Jouyban,et al.  QSAR Analysis of Cyclooxygenase Inhibitors Selectivity Index (COX1/COX2): Application of SVM-RBF and MLR Methods , 2015 .

[14]  Roberto Rittner,et al.  The MIA‐QSAR Method for the Prediction of Bioactivities of Possible Acetylcholinesterase Inhibitors , 2012, Archiv der Pharmazie.

[15]  Paola Gramatica,et al.  Real External Predictivity of QSAR Models. Part 2. New Intercomparable Thresholds for Different Validation Criteria and the Need for Scatter Plot Inspection , 2012, J. Chem. Inf. Model..

[16]  Edward J Ciaccio,et al.  Quantitative image analysis of celiac disease. , 2015, World journal of gastroenterology.

[17]  M. Fromm,et al.  Importance of P-glycoprotein at blood-tissue barriers. , 2004, Trends in pharmacological sciences.

[18]  Paola Gramatica,et al.  External Evaluation of QSAR Models, in Addition to Cross‐Validation: Verification of Predictive Capability on Totally New Chemicals , 2014, Molecular informatics.

[19]  Christoph Globisch,et al.  Synthesis and biological evaluation of a small molecule library of 3rd generation multidrug resistance modulators. , 2009, Bioorganic & medicinal chemistry.

[20]  Roberto Todeschini,et al.  Molecular descriptors for chemoinformatics , 2009 .

[21]  Paola Gramatica,et al.  Principles of QSAR models validation: internal and external , 2007 .

[22]  W. Löscher,et al.  Tariquidar-Induced P-Glycoprotein Inhibition at the Rat Blood–Brain Barrier Studied with (R)-11C-Verapamil and PET , 2008, Journal of Nuclear Medicine.

[23]  Christophe Croux,et al.  TOMCAT: A MATLAB toolbox for multivariate calibration techniques , 2007 .

[24]  A 2D image-based method for modeling some c-Src tyrosine kinase inhibitors , 2013, Medicinal Chemistry Research.

[25]  Z. Binkhathlan,et al.  P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives. , 2013, Current cancer drug targets.

[26]  Roman Rouzier,et al.  Phase II study of tariquidar, a selective P‐glycoprotein inhibitor, in patients with chemotherapy‐resistant, advanced breast carcinoma , 2005, Cancer.

[27]  I. Pajeva,et al.  Protein Contacts and Ligand Binding in the Inward‐Facing Model of Human P‐Glycoprotein , 2013, ChemMedChem.

[28]  J. Dearden,et al.  QSAR modeling: where have you been? Where are you going to? , 2014, Journal of medicinal chemistry.

[29]  R. Todeschini,et al.  Molecular Descriptors for Chemoinformatics: Volume I: Alphabetical Listing / Volume II: Appendices, References , 2009 .

[30]  Aixia Yan,et al.  Prediction of bioactivity of HIV-1 integrase ST inhibitors by multilinear regression analysis and support vector machine. , 2013, Bioorganic & medicinal chemistry letters.

[31]  A. de Juan,et al.  Multivariate image analysis: a review with applications , 2011 .

[32]  J. Dearden,et al.  How not to develop a quantitative structure–activity or structure–property relationship (QSAR/QSPR) , 2009, SAR and QSAR in environmental research.

[33]  Paola Gramatica,et al.  Real External Predictivity of QSAR Models: How To Evaluate It? Comparison of Different Validation Criteria and Proposal of Using the Concordance Correlation Coefficient , 2011, J. Chem. Inf. Model..

[34]  Alexander Golbraikh,et al.  Predictive QSAR modeling workflow, model applicability domains, and virtual screening. , 2007, Current pharmaceutical design.

[35]  Riccardo Leardi,et al.  Application of genetic algorithms for pixel selection in multivariate image analysis for a QSAR study of trypanocidal activity for quinone compounds and design new quinone compounds , 2014 .

[36]  P. Roy,et al.  On Some Aspects of Variable Selection for Partial Least Squares Regression Models , 2008 .

[37]  Svetoslav H. Slavov,et al.  Quantitative correlation of physical and chemical properties with chemical structure: utility for prediction. , 2010, Chemical reviews.

[38]  Shadi Shayanfar,et al.  Is regression through origin useful in external validation of QSAR models? , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[39]  Z. Garkani-Nejad,et al.  Prediction of antihypertensive activity of pyridazinone derivatives through multivariate image analysis applied to QSAR , 2013, Medicinal Chemistry Research.

[40]  R. J. Doerksen,et al.  Quantitative structure-activity relationships of imidazole-containing farnesyltransferase inhibitors using different chemometric methods. , 2013, Medicinal chemistry (Shariqah (United Arab Emirates)).

[41]  Michael Wiese,et al.  Structure-activity relationships of a series of tariquidar analogs as multidrug resistance modulators. , 2006, Bioorganic & medicinal chemistry.

[42]  Steven D. Brown,et al.  MIA-QSAR: a simple 2D image-based approach for quantitative structure–activity relationship analysis , 2005 .

[43]  I. Pajeva,et al.  Structure–Activity Relationships of Tariquidar Analogs as Multidrug Resistance Modulators , 2009, The AAPS Journal.